DAVID LONARD to Epithelial-Mesenchymal Transition
This is a "connection" page, showing publications DAVID LONARD has written about Epithelial-Mesenchymal Transition.
Connection Strength
0.251
-
Development of improved SRC-3 inhibitors as breast cancer therapeutic agents. Endocr Relat Cancer. 2021 08 13; 28(10):657-670.
Score: 0.170
-
Steroid receptor coactivator-2 drives epithelial reprogramming that enables murine embryo implantation. FASEB J. 2023 12; 37(12):e23313.
Score: 0.050
-
Targeting SRC Coactivators Blocks the Tumor-Initiating Capacity of Cancer Stem-like Cells. Cancer Res. 2017 08 15; 77(16):4293-4304.
Score: 0.032